protein physics lecture 24 proteins at action: bind transform release
TRANSCRIPT
![Page 1: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/1.jpg)
PROTEIN PHYSICS
LECTURE 24
PROTEINS AT ACTION:
BIND TRANSFORM RELEASE
![Page 2: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/2.jpg)
BIND: repressors
- turn -
![Page 3: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/3.jpg)
DNA & RNABINDING
Zn-fingers
Leu-zipper
![Page 4: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/4.jpg)
BIND TRANSFORM BIND: Repressors
-BINDING-INDUCED DEFORMATION MAKES REPRESSOR ACTIVE, and IT BINDS TO DNA
![Page 5: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/5.jpg)
BIND: Immunoglobulins
![Page 6: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/6.jpg)
Immunoglobulin
![Page 7: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/7.jpg)
BIND TRANSFORM RELEASE: ENZYMES
Note small active site
chymotrypsin
![Page 8: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/8.jpg)
Chymotrypsin catalyses hydrolysis of a peptide
Spontaneous hydrolysis: very slow
![Page 9: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/9.jpg)
Chymotrypsin
Chymotrypsin is one of the serine proteases.
Chymotrypsin is selective for peptide bonds with aromatic or large hydrophobic side chains, such as Tyr, Trp, Phe and Met, which are on the carboxyl side of this bond. It can also catalyze the hydrolysis of easter bond.
The main catalytic driving force for Chymotrypsin is the set of three amino acid known as catalytic triad. This catalytic pocket is found in the whole serine protease family.
![Page 10: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/10.jpg)
Properties of an Active Site
A shape that fits a specific substrate or substrates only
Side chains that attract the enzyme particular substrate
Side chains specifically positioned to speed the reaction
![Page 11: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/11.jpg)
The Catalytic Triad
![Page 12: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/12.jpg)
chymotrypsin
![Page 13: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/13.jpg)
CHAIN CUT-INDUCED DEFORMATION MAKES ENZYME ACTIVE
Chymotripsin Chymotripsinogen
non-active cat. site
active cat. site
![Page 14: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/14.jpg)
SER-protease: catalysis
![Page 15: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/15.jpg)
![Page 16: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/16.jpg)
Chymotrypsin Protein Hydrolysis
Stage #1
![Page 17: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/17.jpg)
Chymotrypsin Protein Hydrolysis
Stage #2
![Page 18: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/18.jpg)
Chymotrypsin Protein Hydrolysis
Stage #3
![Page 19: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/19.jpg)
Chymotrypsin Protein Hydrolysis
Stage #4
![Page 20: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/20.jpg)
Chymotrypsin Protein Hydrolysis
Stage #5
![Page 21: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/21.jpg)
Chymotrypsin Protein Hydrolysis
Stage #6
![Page 22: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/22.jpg)
Transition State Stabilization
![Page 23: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/23.jpg)
![Page 24: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/24.jpg)
Chymotrypsin Kinetics
The initial "burst" in chymotrypsin-catalysed hydrolysis of the p-nitrophenyl acetate
![Page 25: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/25.jpg)
CHYMOTRYPSIN ACTIVE SITE with INHIBITOR
![Page 26: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/26.jpg)
Catalytic antibodies ABZYM = AntyBody enZYM
Antibodiesare
selectedto TS-likemolecule
Transition state (TS)
Preferentialbinding of TS:RIGID
enzyme
![Page 27: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/27.jpg)
A novel approach to drug delivery:
abzyme-mediated drug activation
Levi Blazer
11/19/04
![Page 28: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/28.jpg)
Immunology ReviewImmunoglobulin G
Monoclonal vs. polyclonal
http://www.path.cam.ac.uk/~mrc7/igs/img09.jpeg
![Page 29: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/29.jpg)
Monoclonal antibody production
Why monoclonal?
Don’t tell PETA
Two forms of hybridoma preps:– Mouse Ascites– In vitro tissue culture.
http://ntri.tamuk.edu/monoclonal/mabcartoon.gif
![Page 30: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/30.jpg)
AbzymesCatalytic monoclonal antibodies: usually IgG, although in theory all Ig subclasses could be created.Created by immunizing an animal against a transition state analog (TSA) of the desired reaction. Any non-lethal TSA antigen that can be coupled to a carrier protein can potentially create a useful abzyme.
En
erg
yΔG
Progress
Abzyme stabilization of transition state
![Page 31: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/31.jpg)
Abzymes – nearly endless possibilities
Acyl-transfer
Cationic cyclization
Disfavored ring closure
Aldol/Michaels
Hydride transfer
Oxy-cope rearrangements
![Page 32: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/32.jpg)
Abzymes
Specific for a particular reaction
But - varied enough to accept a variety of substrates
Can be produced for any non-lethal antigen.
Easier to humanize
![Page 33: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/33.jpg)
Reactive immunization
A novel method to select and create the most catalytically active abzymes.
Use an immunogen that will react a physiological pH or will bind covalently to a B-cell receptor.
![Page 34: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/34.jpg)
Reactive Immunization
Enaminone absorbs at 316 nm
![Page 35: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/35.jpg)
Overview of the old systemADEPT – Antibody directed enzyme prodrug therapyChemically modify a chemotherapy agent to make it minimally toxic.Prepare an antibody-enzyme conjugate that catalyzes the activation reaction Use a localized injection of conjugate to selectively activate drug in tumor tissue.
Chemotherapy agent
Inactivator:Removable throughenzyme/abzyme catalysis
TumorSuppression
![Page 36: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/36.jpg)
Benefits of ADEPT
Minimized toxicity = better!
Localized activation
Potentially lower required doses
![Page 37: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/37.jpg)
Problems with ADEPT
Immunological response to non-host enzyme (the antibody section can be humanized)
Conservation of active sites across species
Selectivity of enzyme
Hard to engineer
![Page 38: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/38.jpg)
Mother Nature: Better than Reingold
Enzymes catalyze many reactions faster and with more specificity than synthetic catalysts.
Problem: difficult to engineer an enzyme if there is no natural analog.
Why not let Mother Nature do the design work for us? -- ABZYME! --
![Page 39: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/39.jpg)
Problems?
Antibodies bind molecules.How can you use this in humans?– Immune response– Diffusion– Protein stability– Side reactions? – Natural activation?
Cost!Ethical concerns.
![Page 40: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/40.jpg)
Methodology:synthesize prodrug with standard inactivator
Administer prodrug and catalytic antibody conjugate separately.
Administer catalytic antibody directly into Tumor.
Localized activation reduces unwanted toxicity
Normal TissueTumor
Y
![Page 41: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/41.jpg)
Doxorubicin activation
By abzyme 38C2
Topoisomerase I & II inhibitor
![Page 42: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/42.jpg)
Prodox synthesis
![Page 43: PROTEIN PHYSICS LECTURE 24 PROTEINS AT ACTION: BIND TRANSFORM RELEASE](https://reader035.vdocument.in/reader035/viewer/2022062300/56649cdc5503460f949a6bea/html5/thumbnails/43.jpg)
Conclusions
Abzyme conjugated ADEPT:– Potentially more effective– Less toxic for non-cancerous cells– Sustainable for long periods of time due to
antibody half-life.